摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氯羰基-6,7-二甲氧基-1-甲基-2(1H)-喹喔啉 | 104077-15-8

中文名称
3-氯羰基-6,7-二甲氧基-1-甲基-2(1H)-喹喔啉
中文别名
3,4-二氢-6,7-二甲氧基-4-甲基-3-氧代喹喔啉-2-羰基氯
英文名称
6,7-Dimethoxy-1-methyl-2-oxo-1H-quinoxaline-3-carbonyl chloride
英文别名
6,7-dimethoxy-1-methyl-2(1H)-quinoxalinone-3-carbonyl chloride;3,4-Dihydro-6,7-dimethoxy-4-methyl-3-oxoquinoxaline-2-carbonyl chloride;6,7-dimethoxy-4-methyl-3-oxoquinoxaline-2-carbonyl chloride
3-氯羰基-6,7-二甲氧基-1-甲基-2(1H)-喹喔啉化学式
CAS
104077-15-8
化学式
C12H11ClN2O4
mdl
MFCD01075069
分子量
282.683
InChiKey
HQUXEWBKFUSDKC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    68.2
  • 氢给体数:
    0
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2933990090

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-氯羰基-6,7-二甲氧基-1-甲基-2(1H)-喹喔啉碘苯二乙酸 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 0.5h, 生成 [4-(3,5-dioxo-1,2,4-triazol-4-yl)phenyl]methyl 6,7-dimethoxy-4-methyl-3-oxoquinoxaline-2-carboxylate
    参考文献:
    名称:
    Synthesis of highly fluorescent dienophiles for detecting conjugated dienes in biological fluid
    摘要:
    具有高荧光取代基的氟源二烯亲体,1,2,4-三氮唑-3,5-二酮衍生物1a、b被合成作为检测带有共轭二烯基的生物化合物的试剂。
    DOI:
    10.1039/c39900001416
  • 作为产物:
    描述:
    N-methyl-2-nitro-4,5-dimethoxyaniline 在 palladium on activated charcoal 盐酸氯化亚砜氢气 作用下, 以 乙醇 为溶剂, 反应 4.0h, 生成 3-氯羰基-6,7-二甲氧基-1-甲基-2(1H)-喹喔啉
    参考文献:
    名称:
    3-取代的6,7-二甲氧基喹喔啉-2(1 h)-ones的制备及其作为氟离子载体的潜力的研究
    摘要:
    描述了制备喹喔啉酮酰氯1和3-甲基喹喔啉酮21的改进途径。这些中间体分别用于获得氟离子载体15-19和27-29。讨论了由氟离子载体络合金属离子的影响。从21获得红色颜料26。
    DOI:
    10.1016/0040-4020(95)00731-m
点击查看最新优质反应信息

文献信息

  • Synthesis of some substituted quinoxalines and polycyclic systems containing the quinoxaline nucleus
    作者:Abid R. Ahmad、Lina K. Mehta、John Parrick
    DOI:10.1039/p19960002443
    日期:——
    The synthesis is described of quinoxalines 11, 14, 15, 16, 20, 21, 23 and 25 of interest as intermediates. The preparation of 21 from 3 by the action of thiourea and the formation of the hexaazapentacycle 23 from sulfide 20 and butylamine are discussed. The methylation of the dione 10 is reinvestigated and the product found to be a mixture of 29 and 30. The preparation of dimethoxyquinoxaline podands, e.g., 32, 33, 34, 40 and 41, tricyclic crown ether 31 and pentacyclic crown ethers, e.g. 38, is described and the effects of metal ions on spectroscopic properties of 40 and 41 are reported.
    所述的合成包括作为中间体的喹唑啉11、14、15、16、20、21、23和25。讨论了从3通过硫脲作用制备21以及从硫化物20和正丁胺形成六氮五元环23的过程。重新研究了二酮10的甲基化,发现产物为29和30的混合物。描述了二甲氧基喹唑啉穴合配体(如32、33、34、40和41)、三环冠醚31和五环冠醚(如38)的制备,并报道了金属离子对40和41光谱性质的影响。
  • METHOD OF EXAMINING AND DIAGNOSING INTEGRATION DYSFUNCTION SYNDROME
    申请人:Mitsubishi Pharma Corporation
    公开号:EP1542017A1
    公开(公告)日:2005-06-15
    The present invention relates to a method of examining or diagnosing schizophrenia, which includes measuring concentrations of D- serine and L- serine in a biological sample. According to the method of the present invention, schizophrenia can be examined or diagnosed by measuring concentrations of D-serine and L-serine in a biological sample by analysis techniques such as high performance liquid chromatography and the like.
    本发明涉及一种检查或诊断精神分裂症的方法,其中包括测量生物样本中 D-丝氨酸和 L-丝氨酸的浓度。根据本发明的方法,可以通过高效液相色谱等分析技术测量生物样本中 D-丝氨酸和 L-丝氨酸的浓度来检查或诊断精神分裂症。
  • INDICATOR FOR ASSESSING BODY ODOR, PROCESS FOR PRODUCING THE SAME, BODY ODOR ASSESSMENT METHOD, METHOD OF ASSESSING EFFICACIOUSNESS OF DEODORANT AND KIT FOR CONVENIENTLY ASSESING BODY ODOR
    申请人:Kao Corporation
    公开号:EP1553411A1
    公开(公告)日:2005-07-13
    An indicator material for assessing body odor of the present invention comprises at least one member selected from the group consisting of a substance (A) which is a β-hydroxycarboxylic acid compound represented by the formula (1), a substance (B) which is a derivative of the compound represented by the formula (1), a substance (C) which is an alcohol compound having a mercapto group at the 3-position represented by the formula (2),and a substance (D) which is a derivative of the compound represented by the formula (2). The present invention also provides a method of producing the compound represented by the formula (2) by incubating perspiration originated from a human in an environment with an oxygen concentration of 10 v/v% or less. The present invention also provides a kit for assessing body odor of a human, wherein the kit for assessing body odor of a human includes a coloration reagent which reacts with β-hydroxycarboxylic acid originated from perspiration of a human. wherein R1 is an alkyl having 1 to 4 carbons; R2 is a hydrogen atom or an alkyl having 1 to 4 carbons, and the total number of carbons in the formula (1) is 10 or less; wherein R3 is a hydrogen atom or methyl group; R4 is an alkyl group having 1 to 3 carbons; and R5 is a hydrogen atom or a methyl group, the total number of carbons is 8 or less.
    本发明的一种用于评估体味的指示剂材料包括至少一种选自以下组成的成员:一种物质(A),它是β-羟基羧酸化合物,由式(1)表示;一种物质(B),它是由式(1)表示的化合物的衍生物;一种物质(C),它是由式(2)表示的在3-位上具有巯基的醇化合物;以及一种物质(D),它是由式(2)表示的化合物的衍生物。本发明还提供了一种通过在氧气浓度为 10 v/v% 或更低的环境中培养人的汗液来生产式(2)所代表的化合物的方法。本发明还提供了一种用于评估人的体味的试剂盒,其中用于评估人的体味的试剂盒包括一种与源自人的汗液的β-羟基羧酸反应的着色试剂。 其中 R1 是具有 1 至 4 个碳原子的烷基;R2 是氢原子或具有 1 至 4 个碳原子的烷基,且式(1)中的碳原子总数为 10 或更少; 其中 R3 是氢原子或甲基;R4 是具有 1 至 3 个碳原子的烷基;R5 是氢原子或甲基,碳原子总数为 8 或更少。
  • Method of examining and diagnosing integration dysfunction syndrome
    申请人:Hashimoto Kenji
    公开号:US20050164400A1
    公开(公告)日:2005-07-28
    The present invention relates to a method of examining or diagnosing schizophrenia, which includes measuring concentrations of D-serine and L-serine in a biological sample. According to the method of the present invention, schizophrenia can be examined or diagnosed by measuring concentrations of D-serine and L-serine in a biological sample by analysis techniques such as high performance liquid chromatography and the like.
    本发明涉及一种检查或诊断精神分裂症的方法,其中包括测量生物样本中 D-丝氨酸和 L-丝氨酸的浓度。 根据本发明的方法,可以通过高效液相色谱等分析技术测量生物样本中 D-丝氨酸和 L-丝氨酸的浓度来检查或诊断精神分裂症。
  • Indicator for assessing body odor, process for producing the same, body odor assessment method, method of assessing efficaciousness of deodorant and kit for conveniently assessing body odor
    申请人:Hasegawa Yoshihiro
    公开号:US20060160240A1
    公开(公告)日:2006-07-20
    An indicator material for assessing body odor of the present invention comprises at least one member selected from the group consisting of a substance (A) which is a β-hydroxycarboxylic acid compound represented by the formula (1), a substance (B) which is a derivative of the compound represented by the formula (1), a substance (C) which is an alcohol compound having a mercapto group at the 3-position represented by the formula (2),and a substance (D) which is a derivative of the compound represented by the formula (2). The present invention also provides a method of producing the compound represented by the formula (2) by incubating perspiration originated from a human in an environment with an oxygen concentration of 10 v/v % or less. The present invention also provides a kit for assessing body odor of a human, wherein the kit for assessing body odor of a human includes a coloration reagent which reacts with β-hydroxycarboxylic acid originated from perspiration of a human.
    本发明的一种用于评估体味的指示剂材料包括至少一种选自以下组成的成员:一种物质(A),它是β-羟基羧酸化合物,由式(1)表示;一种物质(B),它是由式(1)表示的化合物的衍生物;一种物质(C),它是由式(2)表示的在3-位上具有巯基的醇化合物;以及一种物质(D),它是由式(2)表示的化合物的衍生物。本发明还提供了一种通过在氧气浓度为 10 v/v % 或更低的环境中培养人的汗液来生产式(2)所代表的化合物的方法。本发明还提供了一种用于评估人的体味的试剂盒,其中用于评估人的体味的试剂盒包括一种着色试剂,该试剂与源自人的汗液的β-羟基羧酸反应。
查看更多